BDBM50303113 3-(3-(1H-indazol-4-yl)-2-(pyridin-4-yl)-1,2-dihydropyrazolo[1,5-a]pyrimidin-7-yl)-N,N-dimethyl-8-azabicyclo[3.2.1]octane-8-carboxamide::CHEMBL584942

SMILES: CN(C)C(=O)N1C2CCC1CC(C2)c1ccnc2c(c(nn12)-c1ccncc1)-c1cccc2[nH]ncc12

InChI Key: InChIKey=AVQBKIKQPSUKCC-UHFFFAOYSA-N

Data: 1 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50303113   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Serine/threonine-protein kinase B-raf (Homo sapiens (Human))	BDBM50303113 (3-(3-(1H-indazol-4-yl)-2-(pyridin-4-yl)-1,2-dihydr...) Show SMILES CN(C)C(=O)N1C2CCC1CC(C2)c1ccnc2c(c(nn12)-c1ccncc1)-c1cccc2[nH]ncc12 |THB:13:11:5:7.8,(13.39,-1.4,;12.04,-.65,;12.02,.89,;10.72,-1.45,;9.38,-.7,;10.75,-2.98,;10.22,-4.45,;8.7,-5.13,;10.07,-5.1,;11.26,-4.23,;12.8,-5.08,;12.26,-6.55,;11.81,-5.36,;12.26,-8.09,;10.93,-8.86,;10.93,-10.4,;12.26,-11.17,;13.6,-10.4,;15.07,-10.88,;15.98,-9.63,;15.07,-8.37,;13.6,-8.85,;17.51,-9.62,;18.28,-10.96,;19.82,-10.96,;20.59,-9.63,;19.81,-8.29,;18.28,-8.3,;15.14,-12.41,;13.84,-13.24,;13.9,-14.78,;15.26,-15.5,;16.57,-14.67,;18.06,-15.09,;18.92,-13.79,;17.95,-12.58,;16.5,-13.13,)| Show InChI InChI=1S/C28H28N8O/c1-34(2)28(37)35-19-6-7-20(35)15-18(14-19)24-10-13-30-27-25(21-4-3-5-23-22(21)16-31-32-23)26(33-36(24)27)17-8-11-29-12-9-17/h3-5,8-13,16,18-20H,6-7,14-15H2,1-2H3,(H,31,32)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.40	n/a	n/a	n/a	n/a	n/a	n/a
Wyeth Research Curated by ChEMBL					Assay Description Inhibition of B-Raf				Bioorg Med Chem Lett 19: 6957-61 (2009) Article DOI: 10.1016/j.bmcl.2009.10.058 BindingDB Entry DOI: 10.7270/Q2833S34
					More data for this Ligand-Target Pair